Rein Therapeutics, Inc. Restricted Cash, Noncurrent
Rein Therapeutics, Inc. (RNTX) had Restricted Cash, Noncurrent of $568.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2021-03-24
- 2020-09-30: Restricted Cash, Noncurrent $568.00K.
- 2020-06-30: Restricted Cash, Noncurrent $568.00K.
- 2020-03-31: Restricted Cash, Noncurrent $568.00K.
- 2019-12-31: Restricted Cash, Noncurrent $568.00K.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2020-09-30 | $568.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $568.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $568.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $568.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $568.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $568.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $568.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $568.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $568.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $568.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $568.00K 10-Q · filed 2018-05-09 |
| 2016-12-31 | $63.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |